Theravance Biopharma, Inc.

By person

34 insiders · 82 transactions

28.0×

Rick E Winningham holds 28.0 times base salary in stock. $29.36M of shares against $1.05M in salary for 2025.

Salary from the company's own proxy. The shares are what Rick E Winningham last reported holding, valued at $17.00, the price COM was last bought or sold at on the open market here, on 1 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Samaha Eli

10% owner

$20.92M (3)

$5.79M (3)

+$15.12M

9,174,453

$155.98M

+30.8%

Shafer Bradford J

EVP, Gen. Counsel, Secretary

—

$2.71M (8)

−$2.71M

277,831

$4.72M

+37.5%

Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

—

$1.89M (24) scheduled

−$1.89M

226,790

$3.86M

−29.1%

BROSHY ERAN

Director

—

$1.66M (5) scheduled

−$1.66M

44,703

$760.00K

−17.2%

GALA RENEE D

SVP, Chief Financial Officer

—

$1.41M (4)

−$1.41M

157,657

$2.68M

−32.8%

HAUMANN BRETT K

Chief Medical Officer

—

$898.21K (3)

−$898.21K

242,499

$4.12M

+28.8%

MALKIEL BURTON G

Director

$760.21K (3)

—

+$760.21K

115,589

$1.97M

+335.0%

WORBOYS PHILIP D

SVP, RESEARCH & TRANSL SCIENCE

—

$743.06K (4)

−$743.06K

330,752

$5.62M

+82.3%

Hindman Andrew A.

SVP, CHIEF FINANCIAL OFFICER

—

$716.24K (1)

−$716.24K

384,714

$6.54M

+5,951%

GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

—

$592.92K (14)

−$592.92K

314,915

$5.35M

+182.8%

Winningham Rick E

CHIEF EXECUTIVE OFFICER

$245.00K (1)

$559.50K (1)

−$314.50K

1,726,989

$29.36M

+93.3%

HEGDE SHARATHCHANDRA S

SVP, Research

—

$223.17K (2)

−$223.17K

259,900

$4.42M

+49.8%

Fore Henrietta

Director

$143.93K (1)

—

+$143.93K

24,000

$408.03K

+100.0%

PASQUALONE FRANK

SVP, CHIEF BUSINESS OFFICER

$105.36K (1)

—

+$105.36K

429,783

$7.31M

+90.8%

WHITESIDES GEORGE M

Director

$98.76K (1)

—

+$98.76K

249,076

$4.23M

+9.7%

O'Connor Donal

Director

—

$81.83K (2)

−$81.83K

80,213

$1.36M

+791.3%

SABESAN VIJAY

SVP, TECHNICAL OPERATIONS

—

$21.60K (1)

−$21.60K

235,524

$4.00M

+49.0%

PITZER KENNETH R

SVP, PROD STRAT & COMM PLNG

—

380,123

$6.46M

+130.2%

Grimaud Brett A.

SVP, GEN COUNSEL AND SECRETARY

—

355,168

$6.04M

+47.0%

Sawaf Aziz

SVP & CHIEF FINANCIAL OFFICER

—

336,841

$5.73M

+64.7%

LEE JUNNING

Sr. VP, Technical Operations

—

234,071

$3.98M

−5.4%

Miller Aine

SVP, DEV & HEAD OF IRE OFFICE

—

189,826

$3.23M

+30.6%

BRADY ANN

PRESIDENT, TBIL

—

110,319

$1.88M

+42.6%

MITCHELL DEAN J

Director

—

97,213

$1.65M

+710.1%

SULIMAN SHEHNAAZ

SVP, Corp Dev & Strategy

—

97,198

$1.65M

+5,515%

Smaldone Alsup Laurie

Director

—

80,989

$1.38M

—

Gunderson Robert V JR

Director

—

78,940

$1.34M

+97.8%

YOUNG WILLIAM D

Director

—

78,010

$1.33M

+167.9%

PAKIANATHAN DEEPIKA

Director

—

64,074

$1.09M

—

Molineaux Susan

Director

—

51,034

$867.64K

+325.3%

GRAY SUSANNAH

Director

—

48,146

$818.54K

—

RINGROSE PETER S

Director

—

37,999

$646.03K

+146.3%

Grant Jeremy T

Director

—

32,954

$560.26K

—

GSK plc entity

Former 10% Owner

—

$0.00

−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Samaha Eli

1 Jul 2026

10% owner

Sell indirect

37,799

$17.00

$642.63K

Samaha Eli

30 Jun 2026

10% owner

Sell indirect

25,027

$17.13

$428.79K

Samaha Eli

29 Jun 2026

10% owner

Sell indirect

273,871

$17.23

$4.72M

Farnum Rhonda

11 Nov 2024

SVP, COMM & MEDICAL AFFAIRS

Sell

4,000

$9.00

$36.00K

GRAHAM RICHARD A

14 Jul 2023

SVP, RESEARCH & DEVELOPMENT

Sell

2,322

$9.84

$22.85K

GRAHAM RICHARD A

14 Jun 2023

SVP, RESEARCH & DEVELOPMENT

Sell

2,322

$10.69

$24.82K

Farnum Rhonda

8 Jun 2023

SVP, COMM & MEDICAL AFFAIRS

Sell

1,790

$11.13

$19.92K

GRAHAM RICHARD A

15 May 2023

SVP, RESEARCH & DEVELOPMENT

Sell

2,322

$11.26

$26.15K

GRAHAM RICHARD A

14 Apr 2023

SVP, RESEARCH & DEVELOPMENT

Sell

2,323

$11.88

$27.60K

GRAHAM RICHARD A

14 Mar 2023

SVP, RESEARCH & DEVELOPMENT

Sell

2,323

$10.32

$23.97K

Farnum Rhonda

9 Mar 2023

SVP, COMM & MEDICAL AFFAIRS

Sell

4,000

$10.20

$40.80K

GRAHAM RICHARD A

6 Mar 2023

SVP, RESEARCH & DEVELOPMENT

Sell

2,323

$10.05

$23.35K

Winningham Rick E

14 Dec 2022

CHIEF EXECUTIVE OFFICER

Sell

50,000

$11.19

$559.50K

GRAHAM RICHARD A

1 Dec 2022

SVP, RESEARCH & DEVELOPMENT

Sell

2,084

$10.73

$22.36K

Hindman Andrew A.

18 Nov 2022

SVP, CHIEF FINANCIAL OFFICER

Sell

65,000

$11.02

$716.24K

GRAHAM RICHARD A

16 Aug 2022

SVP, DEVELOPMENT

Sell

4,906

$9.71

$47.64K

GRAHAM RICHARD A

9 Aug 2022

SVP, DEVELOPMENT

Sell

15,086

$8.79

$132.61K

Farnum Rhonda

23 May 2022

SVP, COMM & MEDICAL AFFAIRS

Sell

1,081

$8.93

$9.65K

Farnum Rhonda

28 Feb 2022

SVP, COMM & MEDICAL AFFAIRS

Sell

2,356

$10.16

$23.95K

WORBOYS PHILIP D

9 Mar 2021

SVP, Research & Transl Science

Sell

8,829

$20.00

$176.58K

GRAHAM RICHARD A

14 Dec 2020

SVP, Development

Sell

7,500

$19.47

$146.06K

WORBOYS PHILIP D

3 Dec 2020

SVP, Research & Transl Science

Sell

4,246

$18.00

$76.43K

HAUMANN BRETT K

21 Aug 2020

Chief Medical Officer

Sell

25,000

$18.29

$457.24K

WORBOYS PHILIP D

20 Aug 2020

SVP, Research & Transl Science

Sell

17,103

$18.00

$307.85K

SABESAN VIJAY

12 Dec 2019

SVP, Technical Operations

Sell

1,027

$21.03

$21.60K

O'Connor Donal

17 May 2019

Director

Sell

2,673

$20.19

$53.97K

O'Connor Donal

16 May 2019

Director

Sell

1,327

$21.00

$27.87K

HEGDE SHARATHCHANDRA S

5 Mar 2019

SVP, Research

Sell

5,690

$24.50

$139.41K

HEGDE SHARATHCHANDRA S

4 Mar 2019

SVP, Research

Sell

3,343

$25.06

$83.76K

WORBOYS PHILIP D

12 Sep 2018

SVP, Translational Science

Sell

6,393

$28.50

$182.20K

Shafer Bradford J

27 Aug 2018

EVP, Gen. Counsel, Secretary

Sell

7,119

$27.71

$197.28K

GALA RENEE D

15 Aug 2018

SVP, Chief Financial Officer

Sell

1,700

$27.43

$46.62K

GALA RENEE D

15 Aug 2018

SVP, Chief Financial Officer

Sell

39,839

$26.71

$1.06M

GALA RENEE D

14 Aug 2018

SVP, Chief Financial Officer

Sell

2,204

$27.74

$61.14K

Shafer Bradford J

8 Aug 2018

EVP, Gen. Counsel, Secretary

Sell

25,355

$27.85

$706.18K

Shafer Bradford J

7 Aug 2018

EVP, Gen. Counsel, Secretary

Sell

4,127

$28.03

$115.69K

Shafer Bradford J

7 Aug 2018

EVP, Gen. Counsel, Secretary

Sell

1,818

$28.99

$52.71K

Shafer Bradford J

8 Jun 2018

EVP, Gen. Counsel, Secretary

Sell

3,900

$23.66

$92.26K

Shafer Bradford J

6 Jun 2018

EVP, Gen. Counsel, Secretary

Sell

10,140

$24.09

$244.27K

GALA RENEE D

18 May 2018

SVP, Chief Financial Officer

Sell

10,000

$24.29

$242.88K

Shafer Bradford J

6 Sep 2017

EVP, Gen. Counsel, Secretary

Sell

14,670

$30.77

$451.35K

HAUMANN BRETT K

7 Mar 2017

SVP Clin Dev & Chief Med Ofc

Sell

424

$30.80

$13.06K

HAUMANN BRETT K

6 Mar 2017

SVP Clin Dev & Chief Med Ofc

Sell

13,576

$31.52

$427.92K

Shafer Bradford J

3 Mar 2017

EVP, Gen. Counsel, Secretary

Sell

26,829

$31.86

$854.77K

Show all 82 transactions →

Theravance Biopharma, Inc.

By person

Individual transactions

What was left out